Plum SEC
  • Korean Market
  • Privacy Policy

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
OWNR
Raphas
★

Executive Ha Gi-wan Acquires 1,136 Shares via Open Market Purchase, Stake Rises to 0.01%

  06/02/2026, 03:26 PM
EXCH
Raphas
★

Raphas Re-files IND for Phase 2b/3 Trial of Allergic Rhinitis Immunotherapy DF19001 Due to Administrative Procedure Change

  05/28/2026, 10:24 AM
EXCH
Raphas
★

Allergic Rhinitis Immunotherapy DF19001: Phase 2b/3 IND Submission for 336 Patients

  05/22/2026, 01:37 PM
PERI
Raphas
★

Raphas Q1 2026 Results: Revenue Down, Operating Loss Improves, Debt Ratio Slightly Down

  05/15/2026, 03:15 PM
OWNR
Raphas
★

Submission of Large Shareholding Report (No Specific Figures Provided)

  05/12/2026, 11:28 AM
OWNR
Raphas
★

Insider and Major Shareholder Securities Holding Report Filed (No Changes)

  05/12/2026, 10:44 AM
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.